2026Eyl
BAX Sep 2026 · Buy
Baxter International is rated Buy. At the report-date price of $22.80 on September 18, 2026, shares trade at an 18.1% discount to our Fair value of $26.92. The primary downside risk is that $9.67B in debt and turnaround delays contract valuation multiples. The strongest catalyst is positive operating cash flow of $845M self-funding debt paydown as profitability recovers.Latest published research · analyzed 2026-09-20 · current · sources stale